ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Aerovate Therapeutics Inc

Aerovate Therapeutics Inc (AVTE)

2.42
-0.01
(-0.41%)
Closed 28 February 8:00AM
2.42
0.00
( 0.00% )
Pre Market: 9:08PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.42
Bid
2.40
Offer
3.10
Volume
-
0.00 Day's Range 0.00
1.25 52 Week Range 32.415
Market Cap
Previous Close
2.42
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
183,448
Shares Outstanding
28,874,513
Dividend Yield
-
PE Ratio
-0.93
Earnings Per Share (EPS)
-2.62
Revenue
-
Net Profit
-75.52M

About Aerovate Therapeutics Inc

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was US$2.42. Over the last year, Aerovate Therapeutics shares have traded in a share price range of US$ 1.25 to US$ 32.415.

Aerovate Therapeutics currently has 28,874,513 shares in issue. The market capitalisation of Aerovate Therapeutics is US$69.88 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -0.93.

AVTE Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.01-0.4115226337452.432.522.33913892.40930363CS
4-0.185-7.101727447222.6052.682.33904252.45623786CS
12-0.16-6.20155038762.582.732.331834482.54413091CS
260.5730.81081081081.8531.8154855682.44129483CS
52-21.01-89.671361502323.4332.4151.255716824.18928131CS
156-6.91-74.06216505899.3332.4151.252500507.64330395CS
260-25.58-91.35714285712832.4151.252238268.35054011CS

AVTE - Frequently Asked Questions (FAQ)

What is the current Aerovate Therapeutics share price?
The current share price of Aerovate Therapeutics is US$ 2.42
How many Aerovate Therapeutics shares are in issue?
Aerovate Therapeutics has 28,874,513 shares in issue
What is the market cap of Aerovate Therapeutics?
The market capitalisation of Aerovate Therapeutics is USD 69.88M
What is the 1 year trading range for Aerovate Therapeutics share price?
Aerovate Therapeutics has traded in the range of US$ 1.25 to US$ 32.415 during the past year
What is the PE ratio of Aerovate Therapeutics?
The price to earnings ratio of Aerovate Therapeutics is -0.93
What is the reporting currency for Aerovate Therapeutics?
Aerovate Therapeutics reports financial results in USD
What is the latest annual profit for Aerovate Therapeutics?
The latest annual profit of Aerovate Therapeutics is USD -75.52M
What is the registered address of Aerovate Therapeutics?
The registered address for Aerovate Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aerovate Therapeutics website address?
The website address for Aerovate Therapeutics is www.aerovatetx.com
Which industry sector does Aerovate Therapeutics operate in?
Aerovate Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STAKSTAK Inc
US$ 3.58
(130.97%)
12
PMAXPowell Max Ltd
US$ 0.6243
(75.37%)
18.71M
ARBBARB IOT Group Ltd
US$ 0.7913
(64.85%)
5.09M
BONBon Natural Life Ltd
US$ 1.44
(51.58%)
4
BSCSInvesco Bulletshares 2028 Corporate Bond ETF
US$ 29.99
(47.66%)
1
SPGCSacks Parente Golf Inc
US$ 0.1972
(-51.43%)
5.1M
DCGODocGo Inc
US$ 3.01
(-23.21%)
9.61k
ICCTiCoreConnect Inc
US$ 0.9221
(-22.51%)
64.24k
DLODLocal Ltd
US$ 10.68
(-22.33%)
5.3k
SAGSAG Holdings Ltd
US$ 1.55
(-20.51%)
21.62k
VRPXVirpax Pharmaceuticals Inc
US$ 0.2892
(27.29%)
19.09M
PMAXPowell Max Ltd
US$ 0.6243
(75.37%)
18.71M
SPGCSacks Parente Golf Inc
US$ 0.1972
(-51.43%)
5.1M
ARBBARB IOT Group Ltd
US$ 0.795
(65.63%)
5.09M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 12.45
(-0.16%)
4.13M

Your Recent History

Delayed Upgrade Clock